Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchIndependent Academic Research Groups
Research, Drug Development & Manufacturing
Research, Drug Development & ManufacturingClinical Trial Infrastructure
Research, Drug Development & ManufacturingClinical Trial InfrastructureTrial Technology & Data Operations
Research, Drug Development & ManufacturingAcademic & Non-Profit Research

ERT: Clinical Trial Technology Solutions

United States
1 Trial

Clinical trial technology provider (now part of Clario branding) offering neuroscience-focused eCOA and endpoint-quality services for global CNS studies, including methodologies relevant to psychedelic-assisted therapy trials.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Clinical Trial Infrastructure Snapshot

Trial Technology & Data Operations

Service Model

Technology Platform

Coverage

Global

Psychedelic Experience

Verified Psychedelic Trial Experience

Last Verified

Apr 8, 2026

Lifecycle Coverage

Study Startup & Site ActivationTrial Operations & MonitoringData Management & Biostatistics

Phase Coverage

Phase IPhase IIPhase IIIPhase IV / Post-Marketing

Capabilities

ePRO / eCOAEDC / Data PlatformMedical Imaging / EndpointsSafety / Pharmacovigilance

Verification

Verified

Experience Notes

Clario’s neuroscience eCOA materials explicitly reference blinded independent ratings as especially impactful for psychedelic-assisted therapies.

Primary Service Link

Service Notes

Technology-first support for endpoint quality, rater enablement, independent review, and analytics in complex CNS studies.

Source Evidence

Clario — eCOA Neuroscience

https://clario.com/solutions/ecoa/ecoa-neuroscience/

Clario — Home

https://clario.com/

Quick Facts

Type
Other
HQ
United States
Website
Visit

Collaborated Trials

1
CompletedI, II

A Study of Oral Ibogaine in Opioid Withdrawal

Start Date
Compounds
Placebo